These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 201410)

  • 21. An immunoperoxidase assay for the detection of specific IgA antibody in Epstein-Barr virus infections.
    Cevenini R; Donati M; Rumpianesi F; Moroni A; Paolucci P
    J Clin Pathol; 1984 Apr; 37(4):440-3. PubMed ID: 6323549
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective immunodeficiency and malignant lymphoma of the central nervous system. Possible relationship to the Epstein-Barr virus.
    Pattengale PK; Taylor CR; Panke T; Tatter D; McCormick RA; Rawlinson DG; Davis RL
    Acta Neuropathol; 1979 Dec; 48(3):165-9. PubMed ID: 230688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Epstein-Barr virus and human lymphoproliferative disorders.
    Schnipper LE
    Prog Hematol; 1981; 12():275-97. PubMed ID: 6280236
    [No Abstract]   [Full Text] [Related]  

  • 24. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.
    Saemundsen AK; Purtilo DT; Sakamoto K; Sullivan JL; Synnerholm AC; Hanto D; Simmons R; Anvret M; Collins R; Klein G
    Cancer Res; 1981 Nov; 41(11 Pt 1):4237-42. PubMed ID: 6272968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen.
    Rhodes G; Carson DA; Valbracht J; Houghten R; Vaughan JH
    J Immunol; 1985 Jan; 134(1):211-6. PubMed ID: 2981091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of EBNA (Epstein-Barr virus nuclear antigen) antibodies of different immunoglobulin classes.
    Czeglédy J; Gergely L; Váczi L; Szalka A
    Acta Microbiol Acad Sci Hung; 1978; 25(4):237-43. PubMed ID: 224651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epstein-Barr virus and its role in various rheumatic diseases].
    Anan'eva LP; Alekberova ZS; Barinskii IF; Nasonova VA
    Ter Arkh; 1983; 55(7):140-6. PubMed ID: 6312625
    [No Abstract]   [Full Text] [Related]  

  • 28. Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients.
    Purtilo DT; Tatsumi E; Manolov G; Manolova Y; Harada S; Lipscomb H; Krueger G
    Int Rev Exp Pathol; 1985; 27():113-83. PubMed ID: 3017882
    [No Abstract]   [Full Text] [Related]  

  • 29. Epstein-Barr virus infections in childhood.
    Oberender H; Graessner U; Falkenhagen U; Kunkel M; Gärtner L; Kupatz H; Schumacher K
    Acta Virol; 1979 Mar; 23(2):137-42. PubMed ID: 39436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deficient natural killer cell activity in x-linked lymphoproliferative syndrome.
    Sullivan JL; Byron KS; Brewster FE; Purtilo DT
    Science; 1980 Oct; 210(4469):543-5. PubMed ID: 6158759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic significance of determining antibodies to antigens of the Epstein-Barr virus in infectious mononucleosis].
    Urazova LN; Podoplekin VD; Odintsova LN; Lepekhin AV
    Lab Delo; 1989; (5):73-4. PubMed ID: 2473271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hematopathology and Pathogenesis of the X-linked recessive lymphoproliferative syndrome.
    Purtilo DT; Yang JP; Allegra S; DeFlorio D; Hutt LM; Soltani M; Soltani M; Vawter G
    Am J Med; 1977 Feb; 62(2):225-33. PubMed ID: 835602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus-associated lymphoproliferative syndromes: studies in two European families.
    Schuster V; Dohrmann E; Kreth HW
    Cancer Detect Prev; 1991; 15(1):65-7. PubMed ID: 1646073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epstein-Barr virus and infectious mononucleosis. A clinical study of Epstein-Barr antibodies (author's transl)].
    Seigneurin JM; Kressmann MC; Lavoué MF; Saez G; Lenoir G
    Nouv Presse Med; 1978 Dec; 7(44):4005-10. PubMed ID: 215969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. X-linked lymphoproliferative syndrome. An immunodeficiency disorder with acquired agammaglobulinemia, fatal infectious mononucleosis, or malignant lymphoma.
    Purtilo DT
    Arch Pathol Lab Med; 1981 Mar; 105(3):119-21. PubMed ID: 6894075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of enzyme-linked immunosorbent assays with two synthetic peptides of Epstein-Barr virus for diagnosis of infectious mononucleosis.
    Linde A; Kallin B; Dillner J; Andersson J; Jägdahl L; Lindvall A; Wahren B
    J Infect Dis; 1990 May; 161(5):903-9. PubMed ID: 2157771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific neutralizing antibodies in Epstein-Barr virus associated diseases.
    Rocchi G; Hewetson J; Henle W
    Int J Cancer; 1973 May; 11(3):637-47. PubMed ID: 4364719
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro stimulation of lymphocytes of donors seronegative for Epstein-Barr virus by preparations of inactivated Epstein-Barr virus.
    Chang RS; Spina CA
    J Infect Dis; 1976 Jun; 133(6):676-80. PubMed ID: 180190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr-virus immunity and tissue distribution in a fatal case of infectious mononucleosis.
    Britton S; Andersson-Anvret M; Gergely P; Henle W; Jondal M; Klein G; Sandstedt B; Svedmyr E
    N Engl J Med; 1978 Jan; 298(2):89-92. PubMed ID: 201839
    [No Abstract]   [Full Text] [Related]  

  • 40. Epstein-Barr herpesvirus and infectious mononucleosis.
    Miller G
    Prog Med Virol; 1975; 20():84-112. PubMed ID: 172973
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.